Analysis of telomerase activity and RNA expression in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid

Pediatric Blood and Cancer

Volumn 46, Issue 4, 2006, Pages 506-511

  Akiyama, Masaharu ^a   Yamada, Osamy ^b   Yanagisawa, Takaaki ^a   Fujisawa, Kohji ^a   Eto, Yoshikatsu ^a   Yamada, Hisashi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute promyelocytic leukemia cells; All trans retinoic acid; cDNA microarray; Granulocytic differentiation; Telomerase

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CD11B ANTIGEN; GLYCOPROTEIN P 15095; INITIATION FACTOR; PROTEIN BCL 2; RETINOBLASTOMA PROTEIN; RETINOIC ACID; RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER PATIENT; CASE REPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; ENHANCER REGION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; MYELOBLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; TARGET CELL; TUMOR GROWTH;

ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CHILD; DISSEMINATED INTRAVASCULAR COAGULATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GRANULOCYTES; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKOCYTES, MONONUCLEAR; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REMISSION INDUCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TELOMERASE; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 33644672664     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20392     Document Type: Article

References (21)

1. Witcher M, Ross DT, Roisseau C, et al. Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells. Blood 2003;102:237-245.
2. Elstner E, Israeli ML, Le J, et al. Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid. J Clin Invest 1997;99:349-360.
3. Walkley CR, Purton LE, Snelling HJ, et al. Identification of the molecular requirements for an RARα-mediated cell cycle arrest during granulocytic differentiation. Blood 2004;103:1286-1295.
4. Takahashi Y, Breitenbach VL, Zhu J, et al. PML nuclear bodies and apoptosis. Oncogene 2004;23:2819-2824.
5. Akiyama M, Hideshima T, Munshi NC, et al. Telomerase inhibitors as anticancer therapy. Curr Med Chem-Anti-Cancer Agents 2002;2:567-575.
6. Akiyama M, Hideshima T, Shammas MA, et al. Effects of oligonucleotide N3′→P5′ thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells. Cancer Res 2003;63:6187-6194.
7. Morosetti R, Park DJ, Chumakov AM, et al. A novel, myeloid transcription factor, C/EBPε, is upregulated during granulocytic, but not monocytic, differentiation. Blood 1997;90:2591-2600.
8. Harris MN, Ozpolat B, Abdi F, et al. Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia. Blood 2004;104:1314-1323.
9. Kyo S, Inoue M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy? Oncogene 2002;21:688-697.
10. Poole JC, Andrews LG, Tollefsbol TO. Activity, function, and gene regulation of the catalytic subunit of telomerse (hTERT). Gene 2001;269:1-12.
11. Wu KJ, Grandori C, Amacker M, et al. Direct activation of hTERT transcription by c-MYC. Nature Genet 1999;21:220-224.
12. Xu D, Popov N, Hou M, et al. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci USA 2001;98:3826-3831.
13. Akiyama M, Hideshima T, Chauhan D, et al. Cytokines modulate telomerase activity in human multiple myeloma cell line. Cancer Res 2002;62:3876-3882.
14. Liu L. Saldanha SN, Pate MS, et al. Epigenetic regulation of human telomerase reverse transcriptase promotor activity during cellular differentiation. Gene Chromosome Canc 2004;41:26-37.
15. Liu L, Berletch JB, Green JG, et al. Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation. Mol Cancer Ther 2004;3:1003-1009.
16. Moriarty TJ, Dupuis S, Autexier C. Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide. Leukemia 2002;16:1112-1120.
17. Di Noto R, Lo Pardo C, Schiavone EM, et al. All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia. Leuk Lymphoma 1996;21:201-209.
18. Sekiya M, Adachi M, Hinoda Y, et al. Downregulation of Wilms's tumor gene (wt1) during myelomonocytic differentiation in HL60 cells. Blood 1994;83:1876-1882.
19. Chumakov AM, Grillier I, Chumakova E, et al. Cloning of the novel human myeloid-cell-specific C/EBP-ε transcription factor. Mol Cell Biol 1997;17:1375-1386.
20. Liu TX, Zhang JW, Tao J, et al. Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood 2000;96:1496-1504.
21. KIP1 cooperate to promote terminal differentiation of granulocytes and to inhibit myc expression and cyclin E-CDK2 activity. Mol Cell Biol 2002;22:3014-3024.